Literature DB >> 152423

Diagnosis and treatment of ocular rosacea.

S I Brown, L Shahinian.   

Abstract

Eighteen patients with ocular rosacea were treated with oral tetracycline which resulted in marked improvement in all patients. Approximately one half of the patients were able to taper and stop the medication without recurrence of symptoms. The remaining have tapered their medication but could not stop without recurrence of symptoms. The majority of the patients in the series had Staphylococcus aureus on their conjunctiva and lids before and after surgery.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 152423     DOI: 10.1016/s0161-6420(78)35619-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  Tetracycline induced green conjunctival pigment deposits.

Authors:  V L Morrison; D O Kikkawa; B G Herndier
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

2.  Distribution of tetracycline in the conjunctiva of patients on long term systemic doses.

Authors:  P N Dilly; I A Mackie
Journal:  Br J Ophthalmol       Date:  1985-01       Impact factor: 4.638

3.  Oxytetracycline in the treatment of ocular rosacea: a double-blind trial.

Authors:  R S Bartholomew; B J Reid; M J Cheesbrough; M Macdonald; N R Galloway
Journal:  Br J Ophthalmol       Date:  1982-06       Impact factor: 4.638

4.  Placebo controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea.

Authors:  D V Seal; P Wright; L Ficker; K Hagan; M Troski; P Menday
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.